Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02887937 · ClinicalTrials.gov registry record
Cystic Breast Masses by Contrast Enhanced Ultrasound (CEUS)
A clinical trial of Breast Cancer, sponsored by University of Southern California.
- Completed
- Registry status
- 135
- Enrollment target
- 1
- Study location
NCT02887937 is a study of Breast Cancer that has completed, run by University of Southern California. The registered enrollment target is 135 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02887937, a study of Breast Cancer, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 135 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of the proposed research is to evaluate whether qualitative and quantitative parameters in real time contrast enhanced ultrasound (CEUS) can aid in assessing suspicious indeterminate cystic appearing breast masses and ultimately determine whether or not an ultrasound guided biopsy is necessary. The underlying hypothesis is that breast masses (given BIRADS 4) that lack enhancement on CEUS will have a benign histology obtained by ultrasound guided core biopsy and/or surgery. Then, in the future, these non-enhancing cystic lesions can be followed and do not need biopsy intervention.
Conditions Studied
Interventions
- DRUG Definity
Study Locations (1)
California
- USC Department of Radiology - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2016-08-16 |
| Est. Completion | 2018-04-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02887937
The ClinicalTrials.gov registry entry for NCT02887937 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Definity is the first listed.
NCT02887937 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02887937 about?
NCT02887937 is a clinical study titled "Cystic Breast Masses by Contrast Enhanced Ultrasound (CEUS)". The overarching goal of the proposed research is to evaluate whether qualitative and quantitative parameters in real time contrast enhanced ultrasound (CEUS) can aid in assessing suspicious indeterminate cystic appearing breast masses and ultimately determine whether or not an ultrasound guided biop...
What is the current status of trial NCT02887937?
This trial is currently completed. The enrollment target is 135 participants. The study started on 2016-08-16. Estimated completion is 2018-04-29.
What conditions does trial NCT02887937 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT02887937?
The interventions under investigation include: Definity (DRUG).
Who is sponsoring clinical trial NCT02887937?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02887937 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.